Let’s ChatJoin us for an interview with the co-founder of OneSkin, Carolina Reis Oliviera, as we dive into the science of the brand’s efficacious formulations and all the reasons they are leading the way to a universal system for healthier skin. OneSkin is a breakthrough line of skin health products powered by longevity science to address the root causes of aging. While many skincare brands make claims about reversing aging, OneSkin is the first company that quantifies the age reversal effect of their products by measuring changes in the skin at the molecular level. By researching the main driver of skin aging, OneSkin developed a new and proprietary peptide, OS-01, which powers OneSkin products. OS-01 is the first peptide proven to reverse aging by reducing the accumulation of aged senescent cells in human skin models. The result? Healthier, biologically younger, more resilient skin for better overall health and longevity. Shop the brand using the information below for a special discount on your purchase:Code: SKINCAREANARCHYOffer: 15% off entire order for new customers Link: https://www/oneskin.coSupport the Show.Follow The Show On All Socials Using The Tag @skincareanarchy Hosted on Acast. See acast.com/privacy for more information.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare